Show simple item record

dc.contributor.authorGore, M E
dc.contributor.authorHariharan, S
dc.contributor.authorPorta, C
dc.contributor.authorBracarda, S
dc.contributor.authorHawkins, Robert E
dc.contributor.authorBjarnason, G A
dc.contributor.authorOudard, S
dc.contributor.authorLee, S H
dc.contributor.authorCarteni, G
dc.contributor.authorNieto, A
dc.contributor.authorYuan, J
dc.contributor.authorSzczylik, C
dc.date.accessioned2012-01-10T22:40:35Z
dc.date.available2012-01-10T22:40:35Z
dc.date.issued2011-02-01
dc.identifier.citationSunitinib in metastatic renal cell carcinoma patients with brain metastases. 2011, 117 (3):501-9 Canceren
dc.identifier.issn0008-543X
dc.identifier.pmid20862748
dc.identifier.doi10.1002/cncr.25452
dc.identifier.urihttp://hdl.handle.net/10541/201530
dc.description.abstractIn a broad patient population with metastatic renal cell carcinoma (RCC), enrolled in an open-label, expanded access program (EAP), the safety profile of sunitinib was manageable, and efficacy results were encouraging. Here, the authors report results for patients with baseline brain metastases participating in this global EAP.
dc.language.isoenen
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAntineoplastic Agents
dc.subject.meshBrain Neoplasms
dc.subject.meshCarcinoma, Renal Cell
dc.subject.meshDisease-Free Survival
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIndoles
dc.subject.meshKidney Neoplasms
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPyrroles
dc.titleSunitinib in metastatic renal cell carcinoma patients with brain metastases.en
dc.typeArticleen
dc.contributor.departmentRoyal Marsden Hospital NHS Trust, London, United Kingdom.en
dc.identifier.journalCanceren
html.description.abstractIn a broad patient population with metastatic renal cell carcinoma (RCC), enrolled in an open-label, expanded access program (EAP), the safety profile of sunitinib was manageable, and efficacy results were encouraging. Here, the authors report results for patients with baseline brain metastases participating in this global EAP.


This item appears in the following Collection(s)

Show simple item record